Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jul;164(7):1805-1814.
doi: 10.1007/s00701-022-05256-0. Epub 2022 May 26.

C-reactive protein elevation predicts in-hospital deterioration after aneurysmal subarachnoid hemorrhage: a retrospective observational study

Affiliations
Observational Study

C-reactive protein elevation predicts in-hospital deterioration after aneurysmal subarachnoid hemorrhage: a retrospective observational study

Ostini Alessandro et al. Acta Neurochir (Wien). 2022 Jul.

Abstract

Background: There is increasing evidence that inflammation plays a role in the pathogenesis of aneurysmal subarachnoid hemorrhage (aSAH) and in the development of delayed cerebral ischemia (DCI). However, the assessment and interpretation of classically defined inflammatory parameters is difficult in aSAH patients. The objective of this study was to investigate the relationship between easily assessable findings (hyperventilation, fever, white blood cell count (WBC), and C-reactive protein (CRP)) and the occurrence of DCI and unfavorable neurological outcome at discharge in aSAH patients.

Methods: Retrospective analysis of prospectively collected data from a single center cohort. We evaluated the potential of clinical signs of inflammation (hyperventilation, fever) and simple inflammatory laboratory parameters CRP and WBC to predict unfavorable outcomes at discharge and DCI in a multivariate analysis. A cutoff value for CRP was calculated by Youden's J statistic. Outcome was measured using the modified Rankin score at discharge, with an unfavorable outcome defined as modified Rankin scale (mRS) > 3.

Results: We included 97 consecutive aSAH patients (63 females, 34 males, mean age 58 years) in the analysis. Twenty-one (22%) had major disability or died by the time of hospital discharge. Among inflammatory parameters, CRP over 100 mg/dl on day 2 was an independent predictor for worse neurological outcome at discharge. The average C-reactive protein level in the first 14 days was higher in patients with a worse neurological outcome (96.6, SD 48.3 vs 56.3 mg/dl, SD 28.6) in the first 14 days after aSAH. C-reactive protein on day 2 was an indicator of worse neurological outcome. No inflammatory parameter was an independent predictor of DCI. After multivariate adjustment, DCI, increased age, and more than 1 day of mechanical ventilation were significant predictors of worse neurological outcome.

Conclusions: Early elevated CRP levels were a significant predictor of worse neurological outcome at hospital discharge and may be a useful marker of later deterioration in aSAH.

Keywords: C-reactive protein; Delayed cerebral ischemia; Subarachnoid hemorrhage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
C-reactive protein trajectory over the first 14 days after aSAH in patients with favorable (mRankin scale 0–3) and unfavorable (mRankin scale 4–6) neurological outcome
Fig. 2
Fig. 2
Receiver operating characteristic (ROC) curve analysis of CRP at day 2 as a predictive variable for worse neurological outcome. AUC, area under the curve; FPR, false positive rate
Fig. 3
Fig. 3
Receiver operating characteristic (ROC) curve analysis of days of mechanical ventilation as a predictive variable for worse neurological outcome. AUC, area under the curve; FPR, false positive rate
Fig. 4
Fig. 4
Relative importance of single variables in the prediction of higher modified Rankin scale

References

    1. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41:e519–536. doi: 10.1161/STROKEAHA.110.581975. - DOI - PubMed
    1. Amodio S, Bouzat P, Robba C, Taccone FS. Rethinking brain injury after subarachnoid hemorrhage. Crit Care. 2020;24:612. doi: 10.1186/s13054-020-03342-2. - DOI - PMC - PubMed
    1. van Donkelaar CE, Bakker NA, Birks J, Veeger NJGM, Metzemaekers JDM, Molyneux AJ, Groen RJM, van Dijk JMC. Prediction of outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2019;50:837–844. doi: 10.1161/STROKEAHA.118.023902. - DOI - PubMed
    1. Connolly ES, Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, American Heart Association Stroke C. Council on Cardiovascular R, Intervention. Council on Cardiovascular N. Council on Cardiovascular S, Anesthesia. Council on Clinical C Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–1737. doi: 10.1161/STR.0b013e3182587839. - DOI - PubMed
    1. Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care. 2008;8:404–412. doi: 10.1007/s12028-008-9054-2. - DOI - PMC - PubMed

Publication types

Substances